Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID),
Role: Investigator,
National Institute of Allergy and Infectious Diseases/NIH/DHHS,
Status: Completed
For Profit Organization
A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People >/= 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection,
Role: Investigator,
Gilead Sciences, Inc,
(07/2024 - 07/2025)
Status: Approved
Internal
Study on the use of COVID-19 monoclonal antibodies in solid organ transplant patients,
Role: Investigator,
LLU Dept. of Medicine,
(05/2023)
Status: Approved
Epidemiology, Risk Factors, and Outcomes of Solid Organ Transplant Recipients with Early Invasive Mold Infections, a 6-year single center experience covering the COVID-19 Pandemic,
Role: PI,
LLU Dept. of Medicine,
(08/2022)
Status: Approved